Treatment of kaposi's sarcoma with vinblastine

Edmund Klein; Robert Allen Schwartz; Yona Laor; Halina Milgrom; Gordon H. Burgess; Ole A. Holtermann

doi:10.1002/1097-0142(19800201)45:3<427::AID-CNCR2820450304>3.0.CO;2-1

Treatment of kaposi's sarcoma with vinblastine

Edmund Klein, Robert Allen Schwartz, Yona Laor, Halina Milgrom, Gordon H. Burgess, Ole A. Holtermann

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

Abstract

Fourteen patients with Kaposi's sarcoma (KS) were treated systemically with vinblastine sulfate in a low‐dose regimen and compared with 23 patients reported in the medical literature. The therapeutic results in our series were excellent in terms of regression of cutaneous lesions. Vinblastine appears to be a drug that is well suited for the management of KS in an outpatient setting. Intravenous therapy may be supplemented with intralesional or intraarterial vinblastine.

Original language	English (US)
Pages (from-to)	427-431
Number of pages	5
Journal	Cancer
Volume	45
Issue number	3
DOIs	https://doi.org/10.1002/1097-0142(19800201)45:3<427::AID-CNCR2820450304>3.0.CO;2-1
State	Published - Feb 1 1980
Externally published	Yes

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

10.1002/1097-0142(19800201)45:3<427::AID-CNCR2820450304>3.0.CO;2-1

Cite this

@article{d487047119a74b07b454cdf42fb2134b,

title = "Treatment of kaposi's sarcoma with vinblastine",

abstract = "Fourteen patients with Kaposi's sarcoma (KS) were treated systemically with vinblastine sulfate in a low‐dose regimen and compared with 23 patients reported in the medical literature. The therapeutic results in our series were excellent in terms of regression of cutaneous lesions. Vinblastine appears to be a drug that is well suited for the management of KS in an outpatient setting. Intravenous therapy may be supplemented with intralesional or intraarterial vinblastine.",

author = "Edmund Klein and Schwartz, {Robert Allen} and Yona Laor and Halina Milgrom and Burgess, {Gordon H.} and Holtermann, {Ole A.}",

year = "1980",

month = feb,

day = "1",

doi = "10.1002/1097-0142(19800201)45:3<427::AID-CNCR2820450304>3.0.CO;2-1",

language = "English (US)",

volume = "45",

pages = "427--431",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Treatment of kaposi's sarcoma with vinblastine

AU - Klein, Edmund

AU - Schwartz, Robert Allen

AU - Laor, Yona

AU - Milgrom, Halina

AU - Burgess, Gordon H.

AU - Holtermann, Ole A.

PY - 1980/2/1

Y1 - 1980/2/1

N2 - Fourteen patients with Kaposi's sarcoma (KS) were treated systemically with vinblastine sulfate in a low‐dose regimen and compared with 23 patients reported in the medical literature. The therapeutic results in our series were excellent in terms of regression of cutaneous lesions. Vinblastine appears to be a drug that is well suited for the management of KS in an outpatient setting. Intravenous therapy may be supplemented with intralesional or intraarterial vinblastine.

AB - Fourteen patients with Kaposi's sarcoma (KS) were treated systemically with vinblastine sulfate in a low‐dose regimen and compared with 23 patients reported in the medical literature. The therapeutic results in our series were excellent in terms of regression of cutaneous lesions. Vinblastine appears to be a drug that is well suited for the management of KS in an outpatient setting. Intravenous therapy may be supplemented with intralesional or intraarterial vinblastine.

UR - http://www.scopus.com/inward/record.url?scp=0018843488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018843488&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19800201)45:3<427::AID-CNCR2820450304>3.0.CO;2-1

DO - 10.1002/1097-0142(19800201)45:3<427::AID-CNCR2820450304>3.0.CO;2-1

M3 - Article

C2 - 7353196

AN - SCOPUS:0018843488

SN - 0008-543X

VL - 45

SP - 427

EP - 431

JO - Cancer

JF - Cancer

IS - 3

ER -

Treatment of kaposi's sarcoma with vinblastine

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this